pembrolizumab
merck
['lung', 'adaptive ']
don't miss the presentation of br36 (nct04093167), #ctdna molecular response adaptive chemo-immunotherapy for pts with metastatic #lungcancer. will be at #aacr23 poster section #47 board #2 from 9-12.30 today to answer questions! 
Director, @MolecularOncLab & @HopkinsThoracic Biorepository
Co-leader, Molecular Tumor Board @hopkinskimmel. 
Bringing multi-omics discoveries into IO trials.